TLR7 gene effect on hepatic fibrosis progression rate in HIV-infected patients with chronic hepatitis C

The aim of the research – to optimize the prediction of hepatic fibrosis (HF) progression rate in HIV-infected patients with chronic hepatitis C (CHC) based on a comprehensive assessment of general clinical, biochemical, immunological and molecular-genetic markers. Materials and methods. A cross-...

Full description

Bibliographic Details
Published in:	Zaporožskij Medicinskij Žurnal
Main Authors:	L. M. Syzova, T. I. Koval, L. P. Kotsiubailo, O. H. Marchenko
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2019-06-01
Subjects:	HIV infection chronic hepatitis C liver fibrosis prognosis
Online Access:	http://zmj.zsmu.edu.ua/article/view/169093/169289

Similar Items

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

Apoptosis and progression of hepatic fibrosis in hepatitis C patients
by: Maria Isabel Schinoni, et al.

Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people
by: Jessie Torgersen, et al.
Published: (2019-04-01)

The impact of hepatitis E infection on hepatic fibrosis in liver transplanted patients for hepatitis C infection
by: Adriano Claudio Pereira de Moraes, et al.
Published: (2021-05-01)

Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal
by: Adrià Ramírez Mena, et al.
Published: (2022-07-01)

Angiogenesis and experimental hepatic fibrosis
by: Queli Teixeira Lemos, et al.
Published: (2010-08-01)

Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection
by: Barbara Rossetti, et al.
Published: (2021-12-01)

Comparative assessment of liver fibrosis in patients with HIV/chronic hepatitis C co-infection in different ethnic groups
by: Nazgul Sarsekeyeva, et al.
Published: (2016-10-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Risk factors for liver fibrosis progression in patients with chronic hepatitis C
by: Mercedes de Torres, et al.
Published: (2003-01-01)

RANKL inhibits activation of hepatic stellate cells during hepatic fibrosis in mice
by: ZHOU Lijia, et al.
Published: (2023-01-01)

Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants
by: Amir Vahedian-Azimi, et al.
Published: (2021-01-01)

Transient elastography discloses identical distribution of liver fibrosis in chronic hepatitis C between HIV-negative and HIV-positive patients on HAART
by: Grünhage F, et al.
Published: (2010-04-01)

There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV
by: A.R. Souza, et al.
Published: (2008-03-01)

Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after hepatectomy
by: Xiangyong Hao, et al.
Published: (2024-04-01)

The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis
by: Chang Seok Bang, et al.
Published: (2017-05-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Diagnostic values of MMP-9 and TGF-1β in assessing the severity of liver fibrosis and the rate of its progression in patients with chronic hepatitis C GT 1 infection
by: H. V. Venytska, et al.
Published: (2023-07-01)

Annexin A2 Is Associated with Dietary Cholesterol-Induced Metabolic Dysregulation and the Progression of Hepatic Fibrosis
by: Jiayang Liu, et al.
Published: (2026-05-01)

Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in Egypt
by: Amr Abdelkader Fateen, et al.
Published: (2012-07-01)

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapyResearch in context
by: Kasha P. Singh, et al.
Published: (2024-04-01)

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared
by: Gilles Wandeler, et al.
Published: (2016-10-01)

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
by: Nana Zhang, et al.
Published: (2023-02-01)

Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis
by: Eman El-Ahwany, et al.
Published: (2016-01-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

RELATIONSHIP OF THE MARKERS OF ENDOTHELIAL DYSFUNCTION AND FIBROSIS IN CHRONIC HEPATITIS AND CIRRHOSIS
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
by: Qingling Chen, et al.
Published: (2023-09-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

The role of hepatic microenvironment in hepatic fibrosis development
by: Ying Meng, et al.
Published: (2022-12-01)

Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort
by: Shaimaa A. Qaisar, et al.
Published: (2025-03-01)

AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response
by: Feng Liu, et al.
Published: (2024-08-01)

New Approaches to the Diagnosis of Liver Fibrosis in Patients with Chronic Hepatitis C
by: SYu Yu Vasilev, et al.
Published: (2018-06-01)

Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis
by: Nobuharu Tamaki, et al.
Published: (2024-06-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Optimising non-invasive screening for hepatic fibrosis in people living with HIV and intermediate FIB-4 scores
by: Luis Ramos-Ruperto, et al.
Published: (2026-04-01)

Measurement of Liver Fibrosis in Chronic Hepatitis D: Comparison of Invasive and Non-Invasive Methods
by: Sarantuya Gidaagaya, et al.
Published: (2019-03-01)

Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection
by: Costa Luciano Bello, et al.
Published: (2002-01-01)

Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
by: Liangtao Zhao, et al.
Published: (2024-12-01)

Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management
by: Rakesh Kumar Gupta, et al.
Published: (2018-01-01)